Comparing the Effects of the EU- Versus the US-JUUL Pod in a Sample of UK Smokers: Nicotine absorption, Satisfaction, and Other Nicotine-Related Subjective Effects.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Kimber (2023)
Reinforcement enhancement by nicotine: a novel abuse-liability assessment of e-cigarettes in young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kirshenbaum (2022)
Dripping and vape tricks: alternative e-cigarette use behaviors among adolescents.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Kong (2020)
E-cigarette device type and combustible tobacco use: Results from a pooled analysis of 10,482 youth.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kong (2022)
Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Laviolette (2021)
Variations in coil temperature/power and e‐liquid constituents change size and lung deposition of particles emitted by an electronic cigarette
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Lechasseur (2019)
Nicotine Dependence of Electronic Cigarette, Dual Combustible and Electronic Cigarette Users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Lee (2021)
Further investigation of gateway effects using the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Lee (2020)
Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Levy (2019)
Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Liu (2022)